Replimune | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Replimune Group, Inc.
Industry & Market
Funding Information
Headcount Distribution
By Department
Department Breakdown
Keywords & Focus Areas
Overview
Replimune Group, Inc. is a clinical-stage biotechnology company headquartered in Woburn, Massachusetts, with substantial operations in Oxfordshire, UK. Established in 2015 by experienced members of the BioVex Inc. team, it specializes in developing next-generation oncolytic immunotherapies using the proprietary Immulytic® platform for cancer treatment.
The organization’s mission is to create therapies that precisely target and destroy cancer cells while stimulating the immune system to produce an anti-tumor response. Notable achievements include advancing leading clinical candidates such as RP1, RP2, and RP3, with a strategic emphasis on combining oncolytic viruses with checkpoint inhibitors to deliver enhanced clinical outcomes.
Key Metrics
Get Complete Company Metrics
Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.
Contact
Technology Stack
Analytics & Tracking
Social & Marketing
Database & Backend
Cloud & Infrastructure
Productivity
Compare similar companies to Replimune
Compare insights from companies similar to Replimune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
| Company Name | Revenue | No. of Employees | Type | Funding | Founded In | Top Executive |
|---|---|---|---|---|---|---|
| xxxxxxx | $92274 | 43 | Private | - | 3110 | xxxxxxxxxx |
| xxxxxxx | $79761 | 23 | Private | - | 2103 | xxx |
| xxxxxxxxxx | $45774 | 86 | Private | - | 254 | xxxxx |
| xxxxxx | $95835 | 119 | Private | - | 8895 | xxxxxxxxxx |
| xxxxxx | $24222 | 25 | Private | - | 2058 | xxxxxxxxxx |
Discover Similar Companies Instantly
Explore detailed insights and analysis on companies related to your search.